Noctera Targets Menopausal Sleep Without Melatonin
Melatonin has been the default answer for sleep supplements for decades. Bonafide Health’s new product Noctera takes a different approach: a melatonin-free formulation built for perimenopausal and postmenopausal women, combining magnesium glycinate, GABA, L-theanine, and SAMe in a continuous-release delivery system.
Why menopausal sleep is a different problem
Sleep disruption during the menopausal transition is not simply about a shifted circadian rhythm. Estrogen decline destabilizes the hypothalamus’s temperature regulation, triggering hot flashes and night sweats that fragment sleep throughout the night. Melatonin addresses sleep onset timing but doesn’t reach the thermoregulatory or stress physiology components that underlie this kind of disruption.
Consumer research on sleep support priorities reveals the scale of the overlap: 41% of adults seek stress and mood support alongside sleep, and 47% prioritize immune health. Sleep doesn’t exist in isolation from these other systems, and the menopausal experience makes that intersection more acute.
Four ingredients, four pathways
Magnesium glycinate: Magnesium plays a role in GABA receptor function and helps regulate the nervous system. The glycinate chelate form offers superior absorption with minimal digestive side effects. Glycine, the amino acid in the chelate, also has evidence supporting its ability to lower core body temperature, which maps directly to the thermoregulatory issue driving night sweats.
GABA (gamma-aminobutyric acid): The brain’s primary inhibitory neurotransmitter. GABA reduces neural excitability and promotes relaxation. The debate around oral GABA’s ability to cross the blood-brain barrier continues, but recent research increasingly supports indirect effects through the gut-brain axis.
L-theanine: An amino acid found naturally in tea leaves. It increases alpha brain wave activity, producing a state of relaxed alertness without sedation. Clinical studies have shown it reduces sleep latency (time to fall asleep) and decreases mid-sleep awakenings without causing next-day grogginess.
SAMe (S-adenosylmethionine): A naturally occurring compound that serves as a methyl donor in the synthesis of serotonin, dopamine, and melatonin. Rather than supplying melatonin directly, SAMe supports the upstream biochemistry that enables the body to produce its own sleep hormones. Its mood-stabilizing properties are also relevant in the context of menopausal mood shifts.
The continuous-release design
The delivery system is a meaningful element of this formulation. Continuous release means the ingredients are distributed gradually across the night rather than all at once. This addresses the specific sleep challenge most common in menopause: not difficulty falling asleep, but difficulty staying asleep after middle-of-the-night awakenings.
A single-peak release at bedtime wouldn’t cover the second half of the night, when cortisol levels begin rising and night sweats tend to intensify.
Beyond melatonin-only
The supplement market is visibly moving from single-ingredient melatonin solutions toward multi-pathway formulations that address stress physiology, circadian rhythm, and hormonal context simultaneously. Noctera fits squarely within that shift, with the additional specificity of targeting a population, perimenopausal and postmenopausal women, that general sleep supplements have historically under-served.
Sources
Nutritional Outlook (2026). Bonafide Health launches hormone-free supplement for menopause-related sleep disturbances.